Metformin and Time to Sustained Recovery in Adults With COVID-19

Overview of attention for article published in JAMA Internal Medicine, September 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs: 3 blogs
twitter: 15 X users
facebook: 1 Facebook page
reddit: 1 Redditor

video: 1 YouTube creator
bluesky: 13 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 16 X posts from 15 X users, with an upper bound of 195,612 followers.

RT @JAMAInternalMed: In adults with acute mild to moderate #COVID19, metformin did not shorten recovery time compared to placebo, with simi…

In adults with acute mild to moderate #COVID19, metformin did not shorten recovery time compared to placebo, with similar median times to symptom resolution in both groups. https://t.co/fbzuka8U9Z BramanteCarolyn https://t.co/1kRri39bxt

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.